JPMorgan Europe Research Enhanced Index Equity Active (LON:JERA)
London · Delayed Price · Currency is GBP · Price in USD 61.82
+0.08 (0.13%)
Last updated: Jun 11, 2026, 1:32 PM GMT
16.05% (1Y)
| Assets | 2.34B |
| Expense Ratio | 0.25% |
| PE Ratio | 10.22 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +15.81% |
| Volume | 29 |
| Open | 62.11 |
| Previous Close | 61.74 |
| Day's Range | 61.82 - 62.21 |
| 52-Week Low | 51.31 |
| 52-Week High | 64.04 |
| Beta | n/a |
| Holdings | 158 |
| Inception Date | Oct 10, 2018 |
About JERA
JREE.L was created on 2018-10-10 by JPMorgan. The fund's investment portfolio concentrates primarily on total market equity. The Sub-Fund aims to achieve a long-term return in excess of MSCI Europe Index (Total Return Net) (the Benchmark) by actively investing primarily in a portfolio of European companies.
Asset Class Equity
Category Total Market
Stock Exchange London Stock Exchange
Ticker Symbol JERA
Provider JPMorgan
Performance
JERA had a total return of 15.81% in the past year, including dividends. Since the fund's inception, the average annual return has been 19.68%.
Top 10 Holdings
23.45% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 4.54% |
| AstraZeneca PLC | AZN | 2.61% |
| Shell plc | SHEL | 2.38% |
| Siemens Aktiengesellschaft | SIE | 2.22% |
| HSBC Holdings plc | HSBA | 2.15% |
| Nestlé S.A. | NESN | 2.12% |
| Allianz SE | ALV | 2.02% |
| Roche Holding AG | ROP | 1.90% |
| Novartis AG | NOVN | 1.89% |
| Banco Santander, S.A. | SAN | 1.62% |